Exclusive Summary

• Possessing US FDA certification and US market registration serves as a global benchmark for the highest quality, significantly accelerating product approval in target markets.
• As a WHO Essential Medicine and a first-line therapy recommended in major international guidelines, it is a core, indispensable product in hospital settings with massive and stable market demand.
• With original patents long expired in major markets, the competitive landscape is mature, creating a clear market entry opportunity for high-quality, reliably supplied generics.
• It combines the high quality of the US market with the cost-effectiveness of a generic, offering partners a strong, comprehensive competitive edge in both public tenders and private markets.